Research advances in silybin in treatment of drug-induced liver injury

Research advances in silybin in treatment of drug-induced liver injury

Drug-induced liver injury is commonly seen in clinical practice and is usually caused by antipsychotic drugs, antitubercular agents, paracetamol, and statins. Silybin, a substance with biological activity in silymarin extract, has antioxidant, anti-inflammatory, and anti-fibrosis effects. This artic...

Full description

Bibliographic Details
Main Authors:	SHAO Shuang, LIU Chunyan, GAO Yanhang
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2017-06-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=8346

Similar Items

Effect of silybin on high-fat-induced fatty liver in rats
by: Jiayin Yao, et al.
Published: (2011-07-01)

Protective Effect of Silybin in Rats Liver Toxicity
by: Roxana Popescu, et al.
Published: (2010-05-01)

Research advances in drug-induced liver injury
by: YANG Xue
Published: (2020-03-01)

Research advances in drug-induced liver injury
by: YUAN Ling, et al.
Published: (2017-02-01)

Research advances in drug-induced liver injury in the elderly
by: WANG Yuezhi, et al.
Published: (2016-04-01)

Research advances in the pathogenesis of drug-induced liver injury
by: XU Xin, et al.
Published: (2016-02-01)

Research advances in the pathogenesis of drug-induced liver injury
by: WANG Haizhen, et al.
Published: (2018-04-01)

Silybin/Silymarin treatment in chronic hepatitis C
by: Varenka J. Barbero-Becerra, et al.
Published: (2012-09-01)

Recent research advances in chronicity of drug-induced liver injury
by: HUANG Ang
Published: (2020-03-01)

Advances in research and development of new drugs for antiviral therapy for chronic hepatitis B
by: GAO Yanhang, et al.
Published: (2016-11-01)

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
by: Alessandro Federico, et al.
Published: (2017-01-01)

Research Progress of Pharmacogenomics in Drug-Induced Liver Injury
by: Qihui Shao, et al.
Published: (2021-09-01)

The Comparison of The Effects of Silybin and Silybin-Phosphatidylcholine on Viability and ESR Expression in Human Breast Cancer T47D Cell Line
by: Narges Mahmoodi, et al.
Published: (2014-04-01)

Liver Protection Mechanism and Absorption Promotion Technology of Silybin Based on Intelligent Medical Analysis
by: Bingbing Yan, et al.
Published: (2021-01-01)

Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury
by: Christine Lin, et al.
Published: (2016-01-01)

cis–trans Isomerization of silybins A and B
by: Michaela Novotná, et al.
Published: (2014-05-01)

Effect of Silybin on Lipid Profile in Hypercholesterolaemic Rats
by: Senthil Gobalakrishnan, et al.
Published: (2016-04-01)

Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*
by: Nahum Méndez-Sánchez, et al.
Published: (2019-01-01)

Detection of the risk signals of drug-induced liver injury: Challenges and advances
by: JING Jing
Published: (2020-03-01)

Molecular Research on Drug Induced Liver Injury
by: Rolf Teschke, et al.
Published: (2018-01-01)

Research progress in biomarkers of drug-induced liver injury
by: GUO Pei, et al.
Published: (2016-09-01)

Silybin Modulates Collagen Turnover in an In Vitro Model of NASH
by: Beatrice Anfuso, et al.
Published: (2019-04-01)

Continuous Diastereomeric Kinetic Resolution—Silybins A and B
by: David Biedermann, et al.
Published: (2021-09-01)

Proteomics study on the effect of silybin on cardiomyopathy in obese mice
by: Fei Wang, et al.
Published: (2021-03-01)

Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*
by: Nahum Méndez-Sánchez, et al.
Published: (2019-02-01)

Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*
by: Nahum Méndez-Sánchez, et al.
Published: (2021-06-01)

Supersaturated polymeric micelles for oral silybin delivery: the role of the Soluplus–PVPVA complex
by: Chunliu Zhu, et al.
Published: (2019-01-01)

Effects of silybin supplementation on nutrient digestibility, hematological parameters, liver function indices, and liver-specific mi-RNA concentration in dogs
by: Maciej Gogulski, et al.
Published: (2021-06-01)

Recent Advances in Models of Immune-Mediated Drug-Induced Liver Injury
by: Farah Tasnim, et al.
Published: (2021-04-01)

IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY: DIAGNOSIS AND TREATMENT
by: S. I. Pimanov, et al.
Published: (2017-12-01)

The Effect of Silybin Encapsulated in Nanoparticles on oprM Gene Expression in Drug Resistant Isolates of Pseudomonas Aeruginosa
by: Aref Mohammadipour, et al.
Published: (2017-08-01)

Chemo-Enzymatic Synthesis of Silybin and 2,3-Dehydrosilybin Dimers
by: Eva Vavříková, et al.
Published: (2014-04-01)

Engineered silybin nanoparticles educe efficient control in experimental diabetes.
by: Suvadra Das, et al.
Published: (2014-01-01)

Pharmacokinetics of pure silybin diastereoisomers and identification of their metabolites in rat plasma
by: Petr Marhol, et al.
Published: (2015-04-01)

Drug-induced liver injury
by: Jeong Ill Suh
Published: (2020-01-01)

Drug-Induced Liver Injury
by: Eileen E. N. Almario, et al.
Published: (2017-01-01)

Drug-induced Liver Injury
by: Ching-Wen Chang, et al.
Published: (2002)

Research advances in natural drugs for prevention and treatment of nonalcoholic fatty liver disease
by: LIU Baoqing, et al.
Published: (2016-03-01)

The pathogenesis, diagnosis, and treatment of drug-induced liver injury with extrahepatic adverse drug reactions
by: HOU Junxing
Published: (2020-03-01)

Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners
by: Vladimír Křen
Published: (2021-07-01)